Abbott Laboratories Aktie

Abbott Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 850103 / ISIN: US0028241000

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
29.08.2025 14:46:41

Abbott Gets CE Mark For Expanded Indication For Navitor TAVI System

(RTTNews) - Abbott (ABT) has received CE Mark in Europe for an expanded indication for the Navitor transcatheter aortic valve implantation system to treat people with symptomatic, severe aortic stenosis who are at low or intermediate risk for open-heart surgery. The expanded indication was supported by favorable safety and effectiveness outcomes from the VANTAGE study.

Abbott received CE Mark in 2021 for Navitor to treat people with symptomatic, severe aortic stenosis who are at high or extreme surgical risk. With the new approval, Navitor is available in Europe for patients across all surgical risk categories. The Navitor TAVI system is currently approved in the U.S. to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.

For More Such Health News, visit rttnews.com.

Analysen zu Abbott Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Abbott Laboratories 116,02 1,12% Abbott Laboratories